Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders

Kasi Viswanath Routhu; Sridhar Veeraraghavan; Gayatri Swaroop Merikapudi; Babu G; Srikant Viswanadha; Swaroop Vakkalanka

首页> 外文期刊>World Allergy Organization Journal >Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders

【24h】

Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders

机译：哮喘和过敏性疾病的发病机理–1094。RP3133的临床前表征，RP3133是一种新型有效的CRAC通道抑制剂，可用于治疗呼吸系统疾病

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《World Allergy Organization Journal》 |2013年第1期|共页
作者
Kasi Viswanath Routhu; Sridhar Veeraraghavan; Gayatri Swaroop Merikapudi; Babu G; Srikant Viswanadha; Swaroop Vakkalanka;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类变态反应性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Pharmacodynamic evaluation of RP3128, a novel and potent CRAC channel inhibitor in guinea pig models of allergic asthma [J] . Sutovska Martina, Kocmalova Michaela, Franova Sona, European Journal of Pharmacology: An International Journal . 2016,第Null期

机译：新型强效CRAC通道抑制剂RP3128在豚鼠过敏性哮喘模型中的药效学评估
2. The effect of long-term administered CRAC channels blocker on the functions of respiratory epithelium in guinea pig allergic asthma model [J] . Sutovska Martina, Kocmalova Michaela, Joskova Marta, General Physiology and Biophysics . 2015,第2期

机译：长期施用CRAC通道阻滞剂对豚鼠过敏性哮喘模型中呼吸道上皮功能的影响
3. Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis [J] . Arzu Didem Yalcin, Saadet Gumuslu, Gizem Genc, World Allergy Organization Journal . 2013,第SUPPLEMENTa1期

机译：哮喘和过敏性疾病的发病机制–1066。过敏性哮喘和过敏性鼻炎中的铜蓝蛋白氧化酶活性
4. Potent and selective 2-oxoamide inhibitors of phospholipases A2 as novel medicinal agents for the treatment of inflammatory diseases [C] . Efrosini Barbayianni, Georgia Antonopoulou, George Kokotos IUPAC World Congress on Chemistry . 2015

机译：磷脂酶A2的有效和选择性的2-氧代咪唑抑制剂作为治疗炎性疾病的新型药剂
5. Pharmacological Characterization of TAS05567, a Potent and Selective Inhibitor of Spleen Tyrosine Kinase, in Animal Models of Inflammatory Diseases and B-cell Malignancies [D] . 林宏明 2019

机译：TAS05567，脾酪氨酸激酶的强效和选择性抑制剂，在炎症性疾病和B细胞恶性动物模型中的药理特性
6. Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133 a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders [O] . Kasi Viswanath Routhu, Sridhar Veeraraghavan, Gayatri Swaroop Merikapudi, 2013

机译：哮喘和过敏性疾病的机制–1094。RP3133的临床前表征RP3133是一种新型有效的CRAC通道抑制剂可用于治疗呼吸系统疾病
7. Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders [O] . Kasi Routhu, Sridhar Veeraraghavan, Gayatri Merikapudi, 2013

机译：哮喘和过敏性疾病的机制–1094。RP3133的临床前表征，RP3133是一种新型有效的CRAC通道抑制剂，可用于治疗呼吸系统疾病

Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders

著录项

相似文献

相关主题

期刊订阅